Programs

  • Osteosarcoma Cell Viability Research

    DR JENNIFER PERRY, IDENTIFY NEW PATHWAYS THAT ARE REQUIRED FOR THE VIABILITY AND PROLIFERATION OF P 53 / PRB-NULL OSTEO SARCOMA CELLS
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    –